These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 27329191)

  • 1. Differences in Status 1A Heart Transplantation Survival in the Continuous Flow Left Ventricular Assist Device Era.
    Trivedi JR; Rajagopal K; Schumer EM; Birks EJ; Lenneman A; Cheng A; Slaughter MS
    Ann Thorac Surg; 2016 Nov; 102(5):1512-1516. PubMed ID: 27329191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous flow left ventricular assist device technology has influenced wait times and affected donor allocation in cardiac transplantation.
    Taghavi S; Jayarajan SN; Komaroff E; Mangi AA
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1966-71, 1971.e1. PubMed ID: 24613158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of implantable cardioverter-defibrillator in patients awaiting heart transplant in the continuous-flow left ventricular assist device era.
    Trivedi JR; Slaughter MS; Pan Q; Vijaykrishnan R; Gopinathannair R
    Artif Organs; 2021 Aug; 45(8):845-851. PubMed ID: 33529349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
    Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
    Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database.
    Healy AH; Baird BC; Drakos SG; Stehlik J; Selzman CH
    Ann Thorac Surg; 2013 Mar; 95(3):870-5. PubMed ID: 23218024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in continuous-flow left ventricular assist device therapy as a bridge to transplantation: a risk-adjusted comparison using a propensity score-matching analysis.
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; García Sáez D; Amrani M; Bahrami T; De Robertis F; Wahlers T; Banner NR; Popov AF; Simon AR
    Artif Organs; 2015 Mar; 39(3):212-9. PubMed ID: 25175547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged continuous-flow left ventricular assist device support and posttransplantation outcomes: A new challenge.
    Fukuhara S; Takeda K; Polanco AR; Takayama H; Naka Y
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):872-880.e5. PubMed ID: 26896362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation.
    Uriel N; Jorde UP; Woo Pak S; Jiang J; Clerkin K; Takayama H; Naka Y; Schulze PC; Mancini DM
    J Heart Lung Transplant; 2013 Feb; 32(2):188-95. PubMed ID: 23352392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time.
    Dardas T; Mokadam NA; Pagani F; Aaronson K; Levy WC
    J Am Coll Cardiol; 2012 Jul; 60(1):36-43. PubMed ID: 22541833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of total artificial heart and biventricular assist device support as bridge-to-transplantation.
    Cheng A; Trivedi JR; Van Berkel VH; Massey HT; Slaughter MS
    J Card Surg; 2016 Oct; 31(10):648-653. PubMed ID: 27573150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe right ventricular dysfunction is an independent predictor of pre- and post-transplant mortality among candidates for heart transplantation.
    Ravis E; Theron A; Mancini J; Jaussaud N; Morera P; Chalvignac V; Guidon C; Grisoli D; Gariboldi V; Riberi A; Habib G; Mouly-Bandini A; Collart F
    Arch Cardiovasc Dis; 2017 Mar; 110(3):139-148. PubMed ID: 28117247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Differences in Mortality Based on United Network for Organ Sharing Status While Awaiting Heart Transplantation.
    Hsich EM; Blackstone EH; Thuita L; McNamara DM; Rogers JG; Ishwaran H; Schold JD
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of increased time at the highest urgency category on heart transplant outcomes for candidates with ventricular assist devices.
    Colvin M; Miranda-Herrera D; Gustafson SK; Heubner B; Skeans M; Wang X; Snyder JJ; Kasiske BL; Israni AK
    J Heart Lung Transplant; 2016 Mar; 35(3):326-334. PubMed ID: 26520245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Systemic and Device-Related Complications in Patients Bridged to Transplantation With Left Ventricular Assist Devices.
    Lui C; Suarez-Pierre A; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    J Surg Res; 2020 Feb; 246():207-212. PubMed ID: 31605947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart transplantation outcomes in patients with continuous-flow left ventricular assist device-related complications.
    Quader MA; Wolfe LG; Kasirajan V
    J Heart Lung Transplant; 2015 Jan; 34(1):75-81. PubMed ID: 25150620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.